Remove tag decentralised-trials
article thumbnail

Benefits of blockchain in limiting counterfeit drug distribution

European Pharmaceutical Review

Prioritising for a data-driven 2023 An example shared in the paper were paperless mechanisms using blockchain provide an unchangeable and decentralised system for preventing fraud. Additionally, real-time access to data is also available to patients to go through their clinical trials, as well as sponsors, which reduces the cost of trials.

article thumbnail

BD partners with Biocorp on connected self-injection devices

pharmaphorum

Medtech giant Beckton Dickinson (BD) has signed a deal with France’s Biocorp to use the latter’s near-field communication (NFC) tags in injectable devices. The Injay tag can confirm a complete injection and transfer that information via an NFC reader to a smartphone or tablet for review by a healthcare professional.